iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology
- Written by PR Newswire
▶ Robot Bacteriophage against microbiome associated with colorectal cancer
▶ Bacteriophage Improvement Platform technology with a broad antimicrobial activity
▶ Proprietary Technology incorporating CRISPR/Cas Technology
BOSTON, Feb. 15, 2024 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced...














